Advertisements

Analysts remain positive on Aurobindo Pharma, expect stock to return 8-30% after Q3 earnings

Analysts remain positive on Aurobindo Pharma, expect stock to return 8-30% after Q3 earnings.....»»

Category: topSource: moneycontrolFeb 11th, 2019

Analysts remain positive on Varun Beverages post Q3 earnings, expect stock to give up to 37% return

Analysts remain positive on Varun Beverages post Q3 earnings, expect stock to give up to 37% return.....»»

Category: topSource: moneycontrolFeb 19th, 2018

LT hits new high, up 4% post Q3 nos; analysts remain positive, expect stock give up to 31% return

LT hits new high, up 4% post Q3 nos; analysts remain positive, expect stock give up to 31% return.....»»

Category: topSource: moneycontrolJan 31st, 2018

Mid-teen revenue growth likely for healthcare firms

Mid-teen revenue growth likely for healthcare firms.....»»

Category: topSource: mydigitalfcSep 9th, 2018

Cipla rallies 7% as global analysts remain positive post Q3 earnings, management commentary

Cipla rallies 7% as global analysts remain positive post Q3 earnings, management commentary.....»»

Category: topSource: moneycontrolFeb 8th, 2018

Here is what analysts have to say on RIL Q4 FY19 earnings

Here is what analysts have to say on RIL Q4 FY19 earnings.....»»

Category: topSource: moneycontrol16 hr. 23 min. ago

S&P 500, Nasdaq edge higher as earnings season looms

S&P 500, Nasdaq edge higher as earnings season looms.....»»

Category: global-financeSource: reutersApr 8th, 2019

RBL Bank falls 2% as Q3 slippages increase; analysts remain positive

RBL Bank falls 2% as Q3 slippages increase; analysts remain positive.....»»

Category: topSource: moneycontrolJan 29th, 2019

TCS Q3 review: Earnings in line, but supply constraint a factor to watch out for; buy on dips

TCS Q3 review: Earnings in line, but supply constraint a factor to watch out for; buy on dips.....»»

Category: topSource: moneycontrolJan 10th, 2019

TCS stock falls 5% ahead of second quarter earnings

TCS stock falls 5% ahead of second quarter earnings.....»»

Category: topSource: moneycontrolOct 11th, 2018

D-Street Buzz: Sugar stocks zoom after ethanol price hike led by Mawana Sugars, Aurobindo Pharma jumps 3% - Moneycontrol.com

D-Street Buzz: Sugar stocks zoom after ethanol price hike led by Mawana Sugars, Aurobindo Pharma jumps 3% - Moneycontrol.com.....»»

Category: topSource: googlenewsSep 14th, 2018

Nifty likely to trade in a range of 11670-11420; 3 stocks which could give 4-10% return

Nifty likely to trade in a range of 11670-11420; 3 stocks which could give 4-10% return.....»»

Category: topSource: moneycontrolSep 5th, 2018

If you have a 6-month time frame, these 3 stocks could give up to 20-24% return

If you have a 6-month time frame, these 3 stocks could give up to 20-24% return.....»»

Category: topSource: moneycontrolMay 24th, 2018

Cipla shares gain 7% after company turns profitable in Q4; analysts cut EPS estimates

Cipla shares gain 7% after company turns profitable in Q4; analysts cut EPS estimates.....»»

Category: topSource: moneycontrolMay 23rd, 2018

Havells stock: Analysts expect over 30% growth in FY19 earnings

Havells stock: Analysts expect over 30% growth in FY19 earnings.....»»

Category: featuresSource: business-standardMay 13th, 2018

Volatility to rise as we approach Karnataka elections; 3 stocks which could give up to 15% return

Volatility to rise as we approach Karnataka elections; 3 stocks which could give up to 15% return.....»»

Category: topSource: moneycontrolMay 10th, 2018

Prefer auto, pharma select PSU banks; see up to 14% return in these 3 stocks

Prefer auto, pharma select PSU banks; see up to 14% return in these 3 stocks.....»»

Category: topSource: moneycontrolMay 7th, 2018

GNFC Q4 FY18 result review: Utilisation and allocation of cash would be a key factor to watch out for

GNFC Q4 FY18 result review: Utilisation and allocation of cash would be a key factor to watch out for.....»»

Category: topSource: moneycontrolApr 24th, 2018

Not quite festive: Is demand for gold picking up?

Not quite festive: Is demand for gold picking up?.....»»

Category: featuresSource: business-standardApr 19th, 2018

Divi"s stock: Pricing pressure for drug makers can lead to more outsourcing

Divi"s stock: Pricing pressure for drug makers can lead to more outsourcing.....»»

Category: featuresSource: business-standardApr 16th, 2018

Pharma Q4 earnings preview: Tough quarter; US pricing pressure, domestic sales recovery hold key

Pharma Q4 earnings preview: Tough quarter; US pricing pressure, domestic sales recovery hold key.....»»

Category: topSource: moneycontrolApr 12th, 2018